The global antinuclear antibody (ANA) test market is entering a phase of accelerated growth, driven by the rising prevalence of autoimmune diseases and innovations in diagnostic technology. Market valuation is projected to rise from US$ 2,702.6 million in 2025 to US$ 6,538.5 million by 2032, expanding at a CAGR of 13.5% over the forecast period.
Once considered a niche diagnostic tool, the ANA...
The global antinuclear antibody (ANA) test market is entering a phase of accelerated growth, driven by the rising prevalence of autoimmune diseases and innovations in diagnostic technology. Market valuation is projected to rise from US$ 2,702.6 million in 2025 to US$ 6,538.5 million by 2032, expanding at a CAGR of 13.5% over the forecast period.
Once considered a niche diagnostic tool, the ANA...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek